Please login to the form below

Therapy Watch expands its oncology portfolio


This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.

Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/


23rd November 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Guide
How to embrace behavioural science principles in healthcare MR
Research Partnership
Article
A glimmer of hope for Alzheimer’s patients, but at what cost?
Research Partnership
Video
Virtual Conference Live
Research Partnership
Report
Digital Health Tools - Physician Trends
Research Partnership
Webcast
Oncology landscape: How innovative market research methods can navigate you to success
Research Partnership
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership